1.40
+0.04(+2.94%)
Currency In USD
Address
9713 Key West Avenue
Rockville, MD 20850
United States of America
Phone
301 944 1700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
114
First IPO Date
July 30, 2021
| Name | Title | Pay | Year Born |
| Mr. Maher Masoud | President, Chief Executive Officer & Executive Director | 990,004 | 1976 |
| Mr. Ronald Evan Holtz CPA, Ph.D. | Executive Vice President of Administration | 649,385 | 1958 |
| Mr. Ali Soleymannezhad | Chief Commercial Officer | 660,200 | 1981 |
| Mr. Douglas J. Swirsky CFA, CPA | Chief Financial Officer | 700,557 | 1969 |
| Mr. Douglas Arthur Doerfler | Founder | 2.34M | 1956 |
| Mr. Jack Horgan | Vice President of Corporate Development | 0 | N/A |
| Ms. Ana-Paula Martins Fernandes | Senior Vice President of Global Sales | 0 | N/A |
| Mr. Jay Gelfman | Senior Vice President of Operations | 0 | N/A |
| Mr. David Sandoval | Senior Vice President, General Counsel & Corporate Secretary | 0 | 1978 |
| Ms. Jill Mayer | Senior Vice President of Human Resources | 0 | N/A |
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.